Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals-Reference-Cited by-同舟云学术

Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals

Published:2001-12 Issue:5-6 Volume:20 Page:905-913
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Dieye Tandakha Ndiaye,Sow Papa Salif,Simonart Thierry,Guèye-Ndiaye Aı̈ssatou,Popper Stephen J,Delforge Marie-Luce,Dieye Alioune,Sarr Abdoulaye Dieng,Crusiaux Alain,Vooren Jean-Paul Van,Devleeschouwer Michel,Kanki Phyllis,Mboup Souleymane,Diakhate Lamine,Farber Claire-Michèle

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. Quinn TC, Piot P, McCormick JB, et al. Serologic and immunologic studies in patients with AIDS in North America and Africa: the potential role of infectious agents as cofactors in immunodeficiency virus infection. JAMA 1987;257:2617–21.

2. Immune activation is a dominant factor in the pathogenesis of African AIDS;Bentwich;Immunol. Today,1995

3. An inductible transcription factor activates expression of human immunodeficiency virus T cells;Nabel;Nature,1987

4. Gaynor R, Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992:347–63.

5. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure;Zack;Cell,1990

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa;eBioMedicine;2023-07

2. Living with HIV and Getting Vaccinated: A Narrative Review;Vaccines;2023-04-25

3. Tetanus Toxoid;Plotkin's Vaccines;2023

4. HIV infection and the implication for COVID‐19 vaccination;Public Health Challenges;2022-07-29

5. Durability of tetanus seroprotection in people living with HIV;AIDS;2022-02-24